These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31900176)

  • 1. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers.
    Bruckner AL; Losow M; Wisk J; Patel N; Reha A; Lagast H; Gault J; Gershkowitz J; Kopelan B; Hund M; Murrell DF
    Orphanet J Rare Dis; 2020 Jan; 15(1):1. PubMed ID: 31900176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial burden of epidermolysis bullosa on patients in the United States.
    Gorell ES; Wolstencroft PW; de Souza MP; Murrell DF; Linos E; Tang JY
    Pediatr Dermatol; 2020 Nov; 37(6):1198-1201. PubMed ID: 32897588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex.
    So JY; Fulchand S; Wong CY; Li S; Nazaroff J; Gorell ES; de Souza MP; Murrell DF; Teng JM; Chiou AS; Tang JY
    Orphanet J Rare Dis; 2022 Jul; 17(1):270. PubMed ID: 35841105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
    Tang JY; Marinkovich MP; Lucas E; Gorell E; Chiou A; Lu Y; Gillon J; Patel D; Rudin D
    Orphanet J Rare Dis; 2021 Apr; 16(1):175. PubMed ID: 33849616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
    Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
    JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey.
    Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY
    J Am Acad Dermatol; 2021 Nov; 85(5):1161-1167. PubMed ID: 32199895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with epidermolysis bullosa.
    Tabolli S; Sampogna F; Di Pietro C; Paradisi A; Uras C; Zotti P; Castiglia D; Zambruno G; Abeni D
    Br J Dermatol; 2009 Oct; 161(4):869-77. PubMed ID: 19624546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires.
    Hachem ME; Diociaiuti A; Zambruno G; Samela T; Ferretti F; Carnevale C; Linertová R; Bodemer C; Murrell DF; Abeni D
    Ital J Pediatr; 2024 Apr; 50(1):76. PubMed ID: 38637879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
    Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
    Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the estimation of prevalence of epidermolysis bullosa in Japan].
    Inaba Y; Kitamura K; Ogawa H; Manabe M; Sasai Y
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):1021-6. PubMed ID: 2601109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa.
    Paller AS; Pope E; Rudin D; Malyala A; Ramsdell D; Johnson R; Landy H; Murrell DF;
    Orphanet J Rare Dis; 2022 Aug; 17(1):314. PubMed ID: 35964087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family burden in epidermolysis bullosa is high independent of disease type/subtype.
    Tabolli S; Pagliarello C; Uras C; Di Pietro C; Zambruno G; Castiglia D; Sampogna F; Abeni D
    Acta Derm Venereol; 2010 Nov; 90(6):607-11. PubMed ID: 21057744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The generalized atrophic benign form of junctional epidermolysis bullosa. Experience with four patients in the United States.
    Paller AS; Fine JD; Kaplan S; Pearson RW
    Arch Dermatol; 1986 Jun; 122(6):704-10. PubMed ID: 3521495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey.
    Fulchand S; Harris N; Li S; Barriga M; Gorell E; De Souza M; Murrell D; Marinkovich MP; Krishna Yenamandra V; Tang JY
    Pediatr Dermatol; 2021 Sep; 38(5):1198-1201. PubMed ID: 34515355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family caregivers' lived experiences of caring for epidermolysis bullosa patients: A phenomenological study.
    Wu YH; Sun FK; Lee PY
    J Clin Nurs; 2020 May; 29(9-10):1552-1560. PubMed ID: 32043289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family burden of children suffering from epidermolysis bullosa.
    DE Stefano S; Grassi FS; Lalatta F; Scuvera G; Brena M; Grillo P; Peves Rios WE; Guez S
    Ital J Dermatol Venerol; 2021 Oct; 156(5):580-587. PubMed ID: 33034432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermolysis bullosa in Northern Ireland.
    McKenna KE; Walsh MY; Bingham EA
    Br J Dermatol; 1992 Oct; 127(4):318-21. PubMed ID: 1419751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of family impact of recessive dystrophic epidermolysis bullosa using the Italian version of the Family Dermatology Life Quality Index.
    Sampogna F; Tabolli S; Di Pietro C; Castiglia D; Zambruno G; Abeni D
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1151-5. PubMed ID: 22882670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa in France.
    Bourrat E; Taieb C; Marquié A; Causse P; Bergqvist C; Sauvestre A; Bellon N
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):194-203. PubMed ID: 35994204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.